Skip to main content

ProMIS Neurosciences Inc.

PMN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374339

In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding ProMIS Neurosciences Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PMN: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders213+11
Shares83.5K185.0K+101.5K (+121.6%)
Value$468.0K$1.13M+$665.2K (+142.1%)

New holders (13)

Institutions that held ProMIS Neurosciences Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PMN in Q3 2022
InstitutionSharesValue% of portfolio
Northeast Financial Consultants Inc100,000$613.0K0.04%
Ieq Capital, LLC39,191$240.0K0.01%
Bank of America Corp14,349$88.0K0.00%
Claret Asset Management Corp12,330$75.0K0.02%
JPMorgan Chase & Co7,658$47.0K0.00%
Morgan Stanley5,930$36.0K0.00%
UBS Group AG2,912$18.0K0.00%
Royal Bank of Canada1,172$7.00K0.00%
Gables Capital Management Inc.833$5.00K0.00%
National Bank of Canada333$2.00K0.00%
TD Waterhouse Canada Inc.149$1.21K0.00%
AllSquare Wealth Management LLC185$1.00K0.00%
Plante Moran Financial Advisors, LLC2$00.00%

Sold out (2)

Institutions that held ProMIS Neurosciences Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PMN in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Forbes J M & Co LLP73,500$467.0K
White Pine Investment CO10,000$1.00K